Health Care • Medical/Dental Instruments
$1.72 ▼ -0.19
(-9.95%)
MKT CAP: $16.3M • VOL: 17.0K
52W L $2 52W H $19
ROARABLE / RQD
D- • 36/100
PIOTROSKI
2 / 9
MODD // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $0 | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$27.6M | -$19.0M | -$17.5M |
| Operating Margin % | — | — | — |
| Net Income (GAAP) | -$28.2M | -$18.8M | -$17.5M |
| EBITDA (Normalized) | -$24.4M | -$17.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$23.8M | -$15.7M | -$14.0M |
| Capital Expenditures (CapEx) | $3.9M | $2.5M | — |
| Free Cash Flow (FCF) | -$27.7M | -$18.2M | -$14.0M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $2.9M | $7.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $5.9M | $10.3M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MODD.